Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 05.06.2023

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
05.06.23CIRCOR International Enters Definitive Agreement to be Acquired by KKR for $1.6 Billion89BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--CIRCOR International, Inc. ("CIRCOR" or the "Company") (NYSE: CIR), one of the world's leading providers of mission critical flow control products...
► Artikel lesen
05.06.23EQS-News: Obotech Acquisition SE: Redemption Process291OboTech Acquisition SE announces details of the redemption process of its public shares Luxembourg, 5 June 2023 On 5 June 2023, an extraordinary general meeting of the shareholders of OboTech...
► Artikel lesen
05.06.23Criterium Energy Ltd. Consolidation of Common Shares 228Calgary, Alberta--(Newsfile Corp. - June 6, 2023) - Criterium Energy Ltd. (TSXV: CEQ) ("Criterium" or the "Corporation"), an independent upstream energy development and production company focused in...
► Artikel lesen
05.06.23Harsco Corporation announces name change to Enviri Corporation309New brand identity better reflects Company's commitment to developing and refining sustainable solutions to help solve complex environmental challenges PHILADELPHIA, June 05, 2023 (GLOBE NEWSWIRE)...
► Artikel lesen
05.06.23B&S Group S.A.: Executive Team Composition359Mensdorf, Luxembourg - June 05, 2023 Following the recent appointment of Peter van Mierlo as the new CEO of B&S Group S.A., the Company has decided to change the composition of its Executive Team. The...
► Artikel lesen
05.06.23Sprinklr Announces First Quarter Fiscal 2024 Results221NEW YORK--(BUSINESS WIRE)--Sprinklr (NYSE: CXM), the unified customer experience management (Unified-CXM) platform for modern enterprises, today reported financial results for its first quarter...
► Artikel lesen
05.06.23Grupo Aeroportuario del Pacífico, S.A.B. de C.V.: Grupo Aeroportuario del Pacifico Reports in May 2023 A Passenger Traffic Increase of 10.4% Compared to 2022275GUADALAJARA, Mexico, June 05, 2023 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) ("the Company" or "GAP") announces preliminary terminal passenger traffic...
► Artikel lesen
05.06.23MDxHealth Announces its Extraordinary General Shareholders' Meeting805NEWS RELEASE - REGULATED INFORMATION JUNE 5, 2023, 5:30 pm ET/ 23:30 CEST MDxHealth Announces its Extraordinary General Shareholders' Meeting IRVINE, CA, and HERSTAL, BELGIUM - June 5...
► Artikel lesen
05.06.23Coherus BioSciences, Inc.: Coherus Announces Positive Final Overall Survival Results of JUPITER-02 Phase 3 Trial Evaluating Toripalimab in Nasopharyngeal Carcinoma259- Toripalimab plus chemotherapy resulted in a 37% reduction in the risk of death, HR=0.63, versus chemotherapy alone, in nasopharyngeal carcinoma patients - - No treatments are approved for NPC in...
► Artikel lesen
05.06.23View, Inc. Announces Plans for Reverse Stock Split335MILPITAS, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- View, Inc. (Nasdaq: VIEW) ("View" or the "Company") today announced that its Board of Directors (the "Board") has approved a reverse stock split...
► Artikel lesen
05.06.23B2Gold Corp.: B2Gold Declares Second Quarter 2023 Dividend of $0.04 per Share721VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) ("B2Gold" or the "Company") is pleased to announce that its Board of Directors...
► Artikel lesen
05.06.23Motus GI Holdings, Inc.: Motus GI Announces Appointment of Ravit Ram as Chief Financial Officer306Company completes corporate reorganization focused on reducing operating costs while supporting key value creation drivers, including seeking key FDA approvals and pursuit of strategic partnerships...
► Artikel lesen
05.06.23IDT Corporation Reports Third Quarter Fiscal Year 2023 Results658EPS increases to $0.27 per share on revenue of $299 million NEWARK, NJ, June 05, 2023 (GLOBE NEWSWIRE) -- IDT Corporation (NYSE: IDT), a global provider of fintech, cloud communications, and traditional...
► Artikel lesen
05.06.23JOANN, Inc.: JOANN Announces First Quarter Fiscal 2024 Results and Provides Full Year Outlook358Cash used for operations improved $88.4 million and free cash flow increased $89 million year over year Net sales totaled $478.1 million52.1% gross margin on a GAAP basis, a 380-basis point year-over-year...
► Artikel lesen
05.06.23Nasdaq, Inc.: Nasdaq May 2023 Volumes232NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for May 2023 on its investor relations website. A data sheet showing this information can be found...
► Artikel lesen
05.06.23GitLab Inc.: GitLab Reports First Quarter Fiscal Year 2024 Financial Results584Quarterly revenue of $126.9 million, up 45% year-over-year Fiscal First Quarter Highlights: Total revenue of $126.9 millionGAAP operating margin of (46)%; Non-GAAP operating margin of (12)%GAAP net...
► Artikel lesen
05.06.23Erasca, Inc.: Erasca Provides Update on Clinical Program for ERK Inhibitor ERAS-007 and Refines Pipeline301ERAS-007 100 mg BID-QW + encorafenib + cetuximab (EC) in EC-naïve patients with BRAFm CRC showed a 50% (3/6) response rate (2 cPR, 1 uPR), reinforcing ERAS-007 as a potential best-in-class ERK inhibitor...
► Artikel lesen
05.06.23Ocular Therapeutix, Inc.: Ocular Therapeutix To Present 12-Month Top-Line Data from U.S.-Based Phase 1 Clinical Trial of OTX-TKI in Wet Age-Related Macular Degeneration at the 2023 Clinical Trials at the Summit Annual Meeting315BEDFORD, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies...
► Artikel lesen
05.06.23Intellia Therapeutics, Inc.: Intellia Therapeutics Announces Retirement of Jean-François Formela, M.D. From its Board of Directors335CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapeutics...
► Artikel lesen
05.06.23Ultragenyx and Mereo BioPharma Announce Positive Data from the Ongoing Phase 2/3 Orbit Study of Setrusumab (UX143) in Osteogenesis Imperfecta (OI)386Pediatric data show substantial induction of bone production in 1 week and a large increase in bone formation within 3 months of initiating monthly setrusumab treatment Phase 3 sites beginning to screen...
► Artikel lesen
Seite:  Weiter >>